Navigation Links
Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President
Date:7/30/2014

WESTFORD, Mass., July 30, 2014 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced that the Board of Directors has promoted Executive Vice President, Chief Operating Officer and Chief Financial Officer Timothy W. Baker to President of the Company, effective August 1, 2014.  Baker, 53, will continue to serve as CFO and will take the title of President from Michael Davin, who remains Chairman and Chief Executive Officer.

"Tim has been a valued member of Cynosure's leadership team since joining the Company as Executive Vice President and CFO in 2004," Davin said. "He is focused on continuously improving our financial and operating performance and committed to delivering value for our shareholders. Tim played a key strategic role in our June 2013 acquisition of Palomar Medical Technologies; his operational skills and business expertise were keys to successfully completing the integration in just 12 months. We congratulate Tim on this well-deserved promotion."

Before joining Cynosure, Baker served as Vice President, Finance at Stryker Biotech, a division of medical products and services provider Stryker Corporation. From July 2000 to June 2003, Baker served as President and Chief Financial Officer at Photoelectron Corp., a provider of miniature X-ray systems for radiation therapy. From January 1996 to July 2000, he served as Chief Financial Officer and Vice President of Operations at Radionics, Inc., a provider of surgical devices. Baker is a certified public accountant and holds an MBA in operations management.

About Cynosure, Inc.

Cynosure develops and markets laser and light-based aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, liquefy and remove unwanted fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus and ablate sweat glands.  Cynosure's product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd: YAG, picosecond, pulse dye, and Q-switched lasers and intense pulsed light.  Cynosure sells its products globally under the Cynosure, Palomar and ConBio brand names through a direct sales force in the United States, Canada, Mexico, France, Germany, Spain, the United Kingdom, Australia, China, Japan and Korea, and through international distributors in approximately 120 other countries.  For corporate or product information, visit Cynosure's website at www.cynosure.com.

Contact
Scott Solomon
Vice President
Sharon Merrill Associates
617-542-5300
cyno@investorrelations.com

Photo - http://photos.prnewswire.com/prnh/20140729/130910


'/>"/>
SOURCE Cynosure, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Cynosure Reports Second-Quarter 2014 Financial Results
2. Cynosure to Present at 16th Annual Needham Growth Conference
3. Cynosure Announces Successful Settlement of Patent Infringement Lawsuits Against Tria Beauty
4. Cynosure Announces Sale of Burlington, MA Office Building
5. Cynosure Reports Third-Quarter 2013 Financial Results
6. Cynosure Completes Acquisition of Palomar Medical Technologies
7. Cynosure Added to the S&P SmallCap 600 Index
8. Cynosure to Present at UBS Global Healthcare Conference
9. Cynosure Reports First-Quarter 2013 Financial Results
10. Cynosure Announces Presentation of 16 Abstracts at 33rd ASLMS Annual Conference
11. Cynosure Reports Record Revenues for Fourth-Quarter and Full-Year 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , Jan. 18, 2017 ... Summary GlobalData,s new report, "South Korea Insulin Delivery ... the South Korea Insulin Delivery market. The report provides ... and average prices (USD) within market segments - Insulin ... Accessories. The report also provides company shares and ...
(Date:1/18/2017)... Philadelphia Pediatric Medical Device Consortium (PPDC) has announced seed grants ... Consortium chose those companies from eight finalists in a ... The devices under development are a powered orthotic arm brace ... system for emergency situations and a device that gradually corrects ... ...
(Date:1/18/2017)... PUNE, India , January 18, 2017 ... by Product Type and by Application: Global Opportunity Analysis and Industry Forecast, 2014 ... and is expected to reach $1,127 million by 2022, growing at a CAGR ... with two-fifths share, in terms of revenue. Continue ... ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... 2017 , ... Bio-Optronics Inc. is proud to announce the ... to seamlessly integrate and streamline the way researchers prepare and conduct patient visits. ... and improving efficiency significantly for users – a first in the CTMS industry. ...
(Date:1/19/2017)... ... January 19, 2017 , ... Ultimate ... in 2017 who are passionate about making a difference in the lives of ... in Tampa, UMA, a nonprofit healthcare educational institution, has more than 30,000 alumni ...
(Date:1/19/2017)... ... January 19, 2017 , ... For the third year running, ... and the surrounding area, is inaugurating a charity event to help raise ... as Lou Gehrig's disease or motor neurone disease, is a deadly neurological disorder ...
(Date:1/19/2017)... CA (PRWEB) , ... January 18, 2017 , ... The ... while driving during a rain storm by slowing down and increasing the space between ... Fox 40. Los Angeles based car accident attorney Raymond R. Hassanlou notes that, rain ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... designs that will simplify the editing process for all media productions," said Christina ... a package of 30 simplistically styled self-animating paragraphs designed for multi-lined text purposes. ...
Breaking Medicine News(10 mins):